Related Experiment Video

Updated: Aug 14, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Cellular factors may enable squamous carcinoma cells to overcome TGF beta-mediated repression of CDK2 activity

E E Lesaca1, J F Ensley, W A Yeudall

  • 1Laboratory of Cellular Development and Oncology, National Institute of Dental Research, Bethesda, MD 20892, USA.

Oral Oncology
|July 11, 1998
PubMed

Insights

Transforming growth factor beta (TGF-β) affects head and neck cancer cell growth. This study found that cancer cells can evade TGF-β

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Head and neck squamous cell carcinoma (HNSCC) cell lines show varied responses to TGF-β's growth inhibition.
  • Understanding TGF-β's impact on cell cycle regulators is crucial for HNSCC research.
  • Investigating mechanisms of resistance to TGF-β is key to understanding cancer progression.

Purpose of the Study:

  • To analyze the effects of TGF-β on cell cycle regulators in HNSCC.
  • To investigate the expression and activity of cyclin-dependent kinases (CDKs) and their inhibitors.
  • To understand why some HNSCC cells are resistant to TGF-β-induced growth inhibition.

Main Methods:

  • Characterization of HNSCC cell lines for sensitivity to TGF-β.
  • Western blot analysis to assess protein expression levels of CDKs and cyclins.
  • In vitro kinase assays to measure CDK2 activity following TGF-β treatment.

Main Results:

  • TGF-β treatment increased p21 (WAF1/Cip1) levels in all tested HNSCC cell lines.
  • CDK2 activity was inhibited by TGF-β in both sensitive and resistant cell lines.
  • Resistant HNSCC cell lines (HN12, HN30) showed sustained CDK2 activity despite TGF-β exposure.

Conclusions:

  • HNSCC cells can overcome TGF-β-mediated CDK2 inhibition.
  • Upregulation of specific cellular factors in resistant cells allows cell cycle progression.
  • This evasion mechanism may contribute to malignant progression in HNSCC.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...